Ortiz-Islas, E.; Montes, P.; RodrÃguez-Pérez, C.E.; Ruiz-Sánchez, E.; Sánchez-Barbosa, T.; Pichardo-Rojas, D.; Zavala-Tecuapetla, C.; Carvajal-Aguilera, K.; Campos-Peña, V.
Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128.
https://doi.org/10.3390/pharmaceutics17010128
AMA Style
Ortiz-Islas E, Montes P, RodrÃguez-Pérez CE, Ruiz-Sánchez E, Sánchez-Barbosa T, Pichardo-Rojas D, Zavala-Tecuapetla C, Carvajal-Aguilera K, Campos-Peña V.
Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics. 2025; 17(1):128.
https://doi.org/10.3390/pharmaceutics17010128
Chicago/Turabian Style
Ortiz-Islas, Emma, Pedro Montes, Citlali Ekaterina RodrÃguez-Pérez, Elizabeth Ruiz-Sánchez, TalÃa Sánchez-Barbosa, Diego Pichardo-Rojas, Cecilia Zavala-Tecuapetla, Karla Carvajal-Aguilera, and Victoria Campos-Peña.
2025. "Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy" Pharmaceutics 17, no. 1: 128.
https://doi.org/10.3390/pharmaceutics17010128
APA Style
Ortiz-Islas, E., Montes, P., RodrÃguez-Pérez, C. E., Ruiz-Sánchez, E., Sánchez-Barbosa, T., Pichardo-Rojas, D., Zavala-Tecuapetla, C., Carvajal-Aguilera, K., & Campos-Peña, V.
(2025). Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics, 17(1), 128.
https://doi.org/10.3390/pharmaceutics17010128